The CONFORM Pivotal Trial
NCT: NCT05147792 · SUSPENDED
Brief Summary
The CLAAS® device will be evaluated for safety and efficacy by establishing its performance is non-inferior to the commercially available WATCHMAN® and Amulet™ left atrial appendage closure devices in patients with non-valvular atrial fibrillation. Patients who are eligible for the trial will be randomized to receive either the CLAAS device or the WATCHMAN or Amulet™ devices and will be followed for 5 years after device implant.
Frequently Asked Questions
What is The CONFORM Pivotal Trial?
The CONFORM Pivotal Trial is a clinical trial registered under NCT05147792. Current status: SUSPENDED.
What is the status of NCT05147792?
The current status of NCT05147792 (The CONFORM Pivotal Trial) is: SUSPENDED.
When did The CONFORM Pivotal Trial start?
The CONFORM Pivotal Trial started on 2022-05-26.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.